Role of coactivators and corepressors in the induction of the RARβ gene in human colon cancer cells

Biological and Pharmaceutical Bulletin

Volumn 25, Issue 10, 2002, Pages 1298-1302

  Lee, Mi Ock ^a   Kang, Hyo Jin ^a  

^a Sejong University   (South Korea)

Author keywords

CBP p300; Colon cancer; RAR ; Retinoic acid

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; HISTONE DEACETYLASE; PROTEIN P300; RETINOIC ACID RECEPTOR BETA; TRICHOSTATIN A; CREBBP PROTEIN, HUMAN; NUCLEAR PROTEIN; RETINOIC ACID RECEPTOR; TRANSACTIVATOR PROTEIN;

ARTICLE; CANCER CELL; COLON CANCER; GENE INDUCTION; HUMAN; HUMAN CELL; PROMOTER REGION; BIOSYNTHESIS; CELL CULTURE; COLON TUMOR; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY;

COLONIC NEOPLASMS; CREB-BINDING PROTEIN; GENE EXPRESSION REGULATION; HUMANS; NUCLEAR PROTEINS; RECEPTORS, RETINOIC ACID; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED;

EID: 0036783085     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.25.1298     Document Type: Article

References (27)

1. Gudas L., Sporn M. B., Roberts A. B., "The Retinoids," ed. by Sporn M. B., Roberts A. B., Goodman D. S., Raven Press. New York, 1994, pp. 443-520.
2. Moon R. C., Mehta R. G., Basic Life Sci., 52. 213-224 (1990).
3. Lippman S. M., Kessler J. F., Meyksens F. L., Cancer Treat. Rep., 71, 493-515 (1987).
4. Stewart L. V., Thomas M. L., Exp. Cell Res., 233, 321-329 (1997).
5. Pfahl M., Apfel R., Bendik I., Fanjul A., Graupner G., Lee M.-O., LaVista N., Lu X.-P., Piedrafita J., Ortiz M. A., Salbert G., Zhang X.-K. "Vitamins and Hormones," Vol. 49, ed. by Litwack G., Academic Press, San Diego, 1994, pp. 327-381.
6. Mangelsdorf D. J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., Evans R. M., Cell, 83, 835-839 (1995).
7. Chambon P., FASEB J., 10, 940-954 (1996).
8. Minucci S., Pelicci P. G., Semin, Cell Dev. Biol., 10, 215-225 (1999).
9. Lee M.-O., Han S. Y., Jiang S., Park J. H., Kim S. J., Biochem. Pharmacol., 59, 485-496 (2000).
10. Lee S. K., Anzick S. L., Choi J. E., Bubendorf L., Guan X. Y., Jung Y. K., Kallioniemi O. P., Kononen J., Trent J., M., Azorsa D., Jhun B. H., Cheong J. H., Lee Y. C., Meltzer P. S., Lee J. W., J. Biol. Chem., 274, 34283-34293 (1999).
11. Lee S. K., Kim J. H., Lee Y. C., Cheong J., Lee J. W., J. Biol Chem., 275, 12470-12474 (2000).
12. Zhang X.-K., Liu Y., Lee M.-O., Pfahl M., Cancer Res., 54, 5663-5669 (1994).
13. Kang H. J., Song M. R., Lee S. K., Shin E. C., Choi Y. H., Kim S. J., Lee J. W., Lee M.-O., Exp. Cell Res., 256, 545-554 (2000).
14. Leo C., Chen J. D., Gene, 245, 1-11 (2000).
15. Sirchia S. M., Ferguson A. T., Sironi E., Subramanyan S., Orlandi R., Sukumar S., Sacchi N., Oncogene, 19, 1556-1563 (2000).
16. Sucov H. M., Murakami K. K., Evans R. M., Proc. Natl. Acad. Sci. U.S.A., 87, 5392-5396 (1990).
17. Hoffmann B., Lehmann J. M., Zhang X.-K., Hermann T., Graupner G., Pfahl M., Mol. Endocrinol., 4, 1734-1743 (1990).
18. McManus K. J., Hendzel M. J., Biochem. Cell Biol., 79, 253-266 (2001).
19. Giordano A., Avantaggiati M. L., J. Cell Physiol., 181, 218-230 (1999).
20. Kawasaki H., Eckner R., Yao T. P., Taira K., Chiu R., Livingston D. M., Yokoyama K. K., Nature (London), 393, 284-289 (1998).
21. Giles R. H., Peters D. J., Breuning M. H., Trends Genet., 14, 178-183 (1998).
22. Muraoka M., Konishi M., Kikuchi-Yanoshita R., Tanaka K., Shitara N., Chong J. M., Iwama T., Miyaki M., Oncogene, 12, 1565-1569 (1996).
23. Bovenzi V., Momparler R. L., Cancer Chemother. Pharmacol., 48, 71-76 (2001).
24. Wolffe A. P., Jones P. L., Wade P. A., Proc. Natl. Acad. Sci. U.S.A., 96, 6107-6112 (1999).
25. Ng H. H., Bird A., Curr. Opin. Genet. Dev., 9, 158-163 (1999).
26. Cote S., Momparler R. L., Anticancer Drags, 8, 56-61 (1997).
27. Cote S., Momparler R. L., Cell Pharmacol., 2, 221-228 (1995).